Date: 2016-04-17 19:35:18

Telomeres

Gerontology

Stem cells

Ageing

DNA replication

Telomerase

Geron Corporation

Myelodysplastic syndrome

Acute myeloid leukemia

Janus kinase inhibitor

Lenalidomide

Myelofibrosis

Needham & Company 15th Annual Healthcare Conference John Scarlett, M.D. President & CEO, Geron Corporation April 12, 2016

Document is deleted from original location.
Use the Download Button below to download from the Web Archive.

File Size: 1,51 MB